logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Peter C. Taylor

university of oxford

85H指数
812论文数
2.7W被引数
收录论文 182
发表时间
logo
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial洛沙坦和泼尼松龙用于后COVID综合征和心脏炎症：一项随机、双盲、安慰剂对照试验
errNature Communications
IF15.7
err2026-07-30
err0
errOAAI
errValentina O. Puntmann; Eike Nagel; Dietrich Beitzke; Andreas Kammerlander; Inga Voges; Marcus Doerr; Bishwas Chamling; Biykem Bozkurt; Juan Carlos Kaski; Erica Spatz; Eva Herrmann; Gernot Rohde; Philipp DeLeuw; Christine Windemuth-Kieselbach; Sebastian Eckhardt; Peter C. Taylor; Colin Berry
err分享
err收藏
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritis类风湿关节炎中临床疾病活动度、滑膜炎症表型与治疗反应之间的关系
errThe Lancet Rheumatology
IF0
err2025-10-14
err0
PREAI
errClément Triaille; Patrick Durez; Francesco Natalucci; Rik Lories; Peter C Taylor
err分享
err收藏
IL-23 drives uveitis by acting on a population of tissue-resident entheseal TcellsIL-23通过作用于一群组织驻留的 entheseal T细胞来驱动葡萄膜炎。
errJCI INSIGHT
IF6.1
err2025-10-08
err0
errOAAI
errHedley, Robert; Ward, Amy; Chu, Colin J.; Coupland, Sarah E.; Kiriakidis, Serafim; Taylor, Peter C.; Dakin, Stephanie G.; Buckley, Christopher D.; Sherlock, Jonathan; Dick, Andrew D.; Copland, David A.
err分享
err收藏
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications更正：Baricitinib在风险人群中特殊兴趣事件的安全性：来自风湿病学和皮肤病学适应症随机试验数据分析
errAdvances in Therapy
IF4
err2025-07-11
err0
errOAAI
errPeter C. Taylor; Thomas Bieber; Rieke Alten; Torsten Witte; James Galloway; Walter Deberdt; Maher Issa; Ewa Haladyj; Inmaculada De La Torre; Susanne Grond; Andreas Wollenberg
err分享
err收藏
STAT3 phosphorylation in the rheumatoid arthritis immunological synapse类风湿关节炎免疫突触中的STAT3磷酸化
errJournal of Autoimmunity
IF7
err2025-07-02
err0
errOAAI
errHila Novak-Kotzer; Jesusa Capera; Ashwin Jainarayanan; Mirudula Elanchezhian; Salvatore Valvo; Viveka Mayya; Alexandra Zanin-Zhorov; Joanne Macdonald; Peter C. Taylor; Michael L. Dustin
err分享
err收藏
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product比较静脉注射BAT1806（一种托珠单抗生物类似药）与其参比制剂的免疫原性
errRHEUMATOLOGY AND THERAPY
IF2.9
err2025-04-08
err0
errOAAI
errEbbers, Hans C.; Taylor, Peter C.; Leng, Xiaomei; Wei, Wei; Kinsella, Niamh M.; Zhou, Yinbo; Yang, Xiaolei; Chamberlain, Paul
err分享
err收藏
Cosmological gravity on all scales. Part IV. 3 x 2 pt Fisher forecasts for pixelised phenomenological modified gravity所有尺度上的宇宙引力。第四部分。3x2 pt Fisher对像素化现象学修正重力的预测
errJOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS
IF5.9
err2025-02-27
err0
errOAAI
errSrinivasan, Sankarshana; Thomas, Daniel B.; Taylor, Peter L.
err分享
err收藏
Towards better personalized care in rheumatoid arthritis旨在改善类风湿关节炎的个性化护理
errRHEUMATOLOGY
IF4.4
err2025-01-30
err0
PREAI
errTaylor, Peter C.
err分享
err收藏
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints
errJOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
IF6.1
err2025-01-01
err0
errOAAI
errPuntmann, Valentina O.; Beitzke, Dietrich; Kammerlander, Andreas; Voges, Inga; Gabbert, Dominik D.; Doerr, Marcus; Chamling, Bishwas; Bozkurt, Biykem; Kaski, Juan Carlos; Spatz, Erica; Herrmann, Eva; Rohde, Gernot; Deleuw, Philipp; Taylor, Lenka; Windemuth-Kieselbach, Christine; Harz, Cornelia; Santiuste, Marta; Schoeckel, Laura; Hirayama, Juliana; Taylor, Peter C.; Berry, Colin; Nagel, Eike
err分享
err收藏
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?
errTHERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
IF4.1
err2024-10-21
err3
errOAAI
errTaylor, Peter C.; Feist, Eugen; Pope, Janet E.; Nash, Peter; Sibilia, Jean; Caporali, Roberto; Balsa, Alejandro
err分享
err收藏
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
errJOURNAL OF AUTOIMMUNITY
IF7
err2024-09-01
err0
errOAAI
errClanchy, Felix IL.; Borghese, Federica; Bystrom, Jonas; Balog, Attila; Penn, Henry; Hull, Dobrina N.; Mageed, Rizgar A.; Taylor, Peter C.; Williams, Richard O.
err分享
err收藏
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor
errADVANCES IN THERAPY
IF4
err2024-08-07
err2
errOAAI
errCaporali, Roberto; Kadakia, Aditi; Howell, Oliver; Patel, Jayesh; Milligan, Jack; Strengholt, Sander; Barlow, Sophie; Taylor, Peter C.
err分享
err收藏
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo- controlled, phase 2trial
errLANCET RHEUMATOLOGY
IF16.4
err2024-08-01
err2
errOAAI
errWorth, Claudia; Al-Mossawi, M. Hussein; Macdonald, Joanne; Fisher, Benjamin A.; Chan, Antoni; Sengupta, Raj; Packham, Jonathan; Gaffney, Karl; Gullick, Nicola; Cook, Jonathan A.; Corn, Tim H.; Teh, James; Machado, Pedro M.; Taylor, Peter C.; Bowness, Paul
err分享
err收藏
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial
errRHEUMATOLOGY INTERNATIONAL
IF2.9
err2024-07-24
err0
errOAAI
errUhrenholt, Line; Sorensen, Mads E. R.; Lauridsen, Karen B.; Duch, Kirsten; Dreyer, Lene; Christensen, Robin; Hauge, Ellen-Margrethe; Loft, Anne Gitte; Rasch, Mads N. B.; Horn, Hans Christian; Taylor, Peter C.; Nielsen, Kaspar R.; Kristensen, Salome
err分享
err收藏
The Rheumatoid Arthritis Impact of Disease (RAID) Score in Telemedicine Management of Rheumatoid Arthritis
errJOURNAL OF RHEUMATOLOGY
IF3.4
err2024-07-01
err0
errOAAI
errTaylor, Peter C.
err分享
err收藏
DIRECT AND INDIRECT EFFECTS OF UPADACITINIB OR ADALIMUMAB ON PAIN IN RHEUMATOID ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY乌帕替尼或阿达木单抗对类风湿关节炎疼痛的直接和间接影响：一项随机III期研究的结果
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errTaylor, P. C.; Walsh, D. A.; Takeuchi, T.; Fautrel, B.; Pope, J.; Garrison, A.; Song, Y.; Penn, S. K.; Lippe, R.; Caballero, D.; Kavanaugh, A.
err分享
err收藏
ASSOCIATION BETWEEN PATIENT-REPORTED PAIN AND ACHIEVING REMISSION OR LOW DISEASE ACTIVITY AT 3 MONTHS IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE RA-BE-REAL STUDY类风湿关节炎患者3个月时达到缓解或低疾病活动度与患者报告的疼痛之间的关联：来自RA-BE-REAL研究
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errTaylor, P. C.; Fakhouri, W.; Ogwu, S.; Haladyj, E.; Fautrel, B.; Alten, R.; Nash, P.; Feist, E.
err分享
err收藏
ASSOCIATION OF EARLY REMISSION ON CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: POST-HOC ANALYSIS OF DATA FROM THE SELECT-COMPARE STUDY早期缓解与类风湿关节炎患者临床及患者报告结局的关联：SELECT-COMPARE研究数据的回顾性分析
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errGossec, L.; Patel, J.; Kadakia, A.; Fang, S.; Peng, Y.; Strengholt, S.; Taylor, P. C.; Ostor, A.
err分享
err收藏
DO HIGH RHEUMATOID FACTOR LEVELS IMPACT RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH INADEQUATELY CONTROLLED RHEUMATOID ARTHRITIS? A POST HOC ANALYSIS OF THE PHASE 3B REALISTIC TRIAL高类风湿因子水平是否影响certolizumab pegol在控制不佳的类风湿关节炎患者中的应答？——REALISTIC三期B阶段试验的事后分析
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errSmolen, J. S.; Mikuls, T.; Galloway, J.; Mueller-Ladner, U.; Curtis, J. R.; Hashimoto, M.; Takeuchi, T.; Choy, E.; Tanaka, Y.; Cara, C.; Lauwerys, B.; Tilt, N.; Ufuktepe, B.; Taylor, P. C.
err分享
err收藏
DIRECT AND INDIRECT EFFECTS OF UPADACITINIB OR ADALIMUMAB ON PAIN IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY乌帕替尼或adalimumab对银屑病关节炎疼痛的直接和间接影响：一项随机第3期研究的结果
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errTaylor, P. C.; Walsh, D. A.; Takeuchi, T.; Fautrel, B.; Pope, J.; Kato, K.; Setty, A.; Gao, T.; Caballero, D.; Lippe, R.; Kavanaugh, A.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
T
Trevor W. Robbins
H 指数: 242 · 论文数: 4.1K
P
Paul Emery
H 指数: 158 · 论文数: 1.6K
D
Désirée van der Heijde
H 指数: 158 · 论文数: 1.3K
P
Paul M. Matthews
H 指数: 151 · 论文数: 855
I
Iain B. McInnes
H 指数: 144 · 论文数: 1.3K
查看更多